Subscribe
Today
Financial
Technology
Cyclical
Defensive
Healthcare
Energy
Industrials
Real Estate
Materials
Viewpoints
All Access Articles |
VRDN
Viridian Therapeutics – Positive Phase 3 Results for Veligrotug in Chronic Thyroid Eye Disease
| 2024-12-16 |
MEDICAL SPECIALITIES
What's the Media Buzz Surrounding Viridian Therapeutics (VRDN)?
| 2024-01-08 |
PHARMACEUTICAL
